SCHEMBL8546408

SCHEMBL8546408

COc1ccc2[nH]cc(CN(C)C)c2c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.52
HTR2A P28223 3/20 0.49
HTR2C P28335 2/20 0.49
HTR2B P41595 2/20 0.49
HTR6 P50406 2/20 0.48
CYP2D6 P10635 2/20 0.43
MEN1 O00255 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SLC6A4 P31645 5/20 0.41
SLC6A2 P23975 3/20 0.41
SLC6A3 Q01959 3/20 0.41
IDO1 P14902 1/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8543450 0.86 HTR1A (0.71) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL5680434 0.84 HTR1A (0.53) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL8549160 0.83 HTR2A (0.45) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL8869200 0.82 SLC6A4 (0.51) HTR1AHTR2AHTR2CHTR2BCYP2D6
SCHEMBL8549767 0.82 HTR2A (0.44) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL1196109 0.82 HTR1A (0.75) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL8545281 0.80 HTR2A (0.56) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL2541508 0.79 HTR2A (0.65) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL29445150 0.79 HTR6 (0.74) HTR1AHTR2AHTR2CHTR2BHTR6
SCHEMBL13390751 0.79 HTR6 (0.74) HTR1AHTR2AHTR2CHTR2BHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593513-B1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1998-10-28 EP disclosed
US-5571833-A TREATMENT OF MIGRAINE, PORTAL HYPERTENSION SMITHKLINE BEECHAM PLC (GB) 1996-11-05 US disclosed
EP-0593513-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES SMITHKLINE BEECHAM PLC (GB) 1994-04-27 EP disclosed
WO-1993000333-A1 TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-01-07 WO disclosed